国际肿瘤学杂志››2022,Vol. 49››Issue (12): 745-748.doi:10.3760/cma.j.cn371439-20220816-00146
收稿日期:
2022-08-16修回日期:
2022-09-26出版日期:
2022-12-08发布日期:
2023-01-05通讯作者:
卢强 E-mail:luqiang@fmmu.edu.cnXiang Guangyu1, Li Jiahe1, Ji Gang2, Guo Xin2, Lu Qiang3()
Received:
2022-08-16Revised:
2022-09-26Online:
2022-12-08Published:
2023-01-05Contact:
Lu Qiang E-mail:luqiang@fmmu.edu.cn摘要:
单细胞RNA测序(scRNA-seq)技术可以描述单个肿瘤细胞中基因表达的变化,揭示肿瘤细胞的状态和功能,捕捉细胞群中广泛的转录组异质性。利用scRNA-seq可监测食管鳞状细胞癌(ESCC)体内特异性高表达的基因和肿瘤细胞中具有某些放、化疗抗性相关的基因,有助于为ESCC提供更精准的辅助诊断依据,评估患者的复发风险和生存时间。深入地研究ESCC中肿瘤细胞与肿瘤微环境间的关系,将为开发出新的ESCC免疫治疗方案提供理论基础。
向光宇, 李家贺, 季刚, 郭欣, 卢强. 单细胞RNA测序技术在食管鳞状细胞癌辅助诊疗中的应用[J]. 国际肿瘤学杂志, 2022, 49(12): 745-748.
Xiang Guangyu, Li Jiahe, Ji Gang, Guo Xin, Lu Qiang. Application of single-cell RNA-seq technology in the auxiliary diagnosis and treatment of esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2022, 49(12): 745-748.
[1] | Li H, Ding C, Zeng H, et al. Improved esophageal squamous cell carcinoma screening effectiveness by risk-stratified endoscopic screening: evidence from high-risk areas in China[J]. Cancer Commun (Lond), 2021, 41(8): 715-725. DOI: 10.1002/cac2.12186. doi:10.1002/cac2.12186 |
[2] | He H, Chen N, Hou Y, et al. Trends in the incidence and survival of patients with esophageal cancer: a SEER database analysis[J]. Thorac Cancer, 2020, 11(5): 1121-1128. DOI: 10.1111/1759-7714.13311. doi:10.1111/1759-7714.13311pmid:32154652 |
[3] | Xu J, Liao K, Yang X, et al. Correction to: using single-cell seque-ncing technology to detect circulating tumor cells in solid tumors[J]. Mol Cancer, 2022, 21(1): 100. DOI: 10.1186/s12943-022-01564-2. doi:10.1186/s12943-022-01564-2 |
[4] | Krämer M, Plum PS, Velazquez Camacho O, et al. Cell type-specific transcriptomics of esophageal adenocarcinoma as a scalable alternative for single cell transcriptomics[J]. Mol Oncol, 2020, 14(6): 1170-1184. DOI: 10.1002/1878-0261.12680. doi:10.1002/1878-0261.12680pmid:32255255 |
[5] | Wu H, Yu J, Li Y, et al. Single-cell RNA sequencing reveals diverse intratumoral heterogeneities and gene signatures of two types of esophageal cancers[J]. Cancer Lett, 2018, 438: 133-143. DOI: 10.1016/j.canlet.2018.09.017. doi:S0304-3835(18)30572-Xpmid:30223068 |
[6] | Feng Z, Qu J, Liu X, et al. Integrated bioinformatics analysis of differentially expressed genes and immune cell infiltration charac-teristics in esophageal squamous cell carcinoma[J]. Sci Rep, 2021, 11(1): 16696. DOI: 10.1038/s41598-021-96274-y. doi:10.1038/s41598-021-96274-y |
[7] | Zheng L, Li L, Xie J, et al. Six novel biomarkers for diagnosis and prognosis of esophageal squamous cell carcinoma: validated by scRNA-seq and qPCR[J]. J Cancer, 2021, 12(3): 899-911. DOI: 10.7150/jca.50443. doi:10.7150/jca.50443pmid:33403046 |
[8] | 中国医师协会放射肿瘤治疗医师分会; 中华医学会放射肿瘤治疗学分会; 中国抗癌协会肿瘤放射治疗专业委员会. 中国食管癌放射治疗指南(2021年版)[J]. 国际肿瘤学杂志, 2022, 49(1): 12-25. DOI: 10.3760/cma.j.cn371439-20211021-00002. doi:10.3760/cma.j.cn371439-20211021-00002 |
[9] | Zhou H, Wang G, Xiao Z, et al. NRAGE confers radiation resistance in 2D and 3D cell culture and poor outcome in patients with esophageal squamous cell carcinoma[J]. Front Oncol, 2022, 12: 831506. DOI: 10.3389/fonc.2022.831506. doi:10.3389/fonc.2022.831506 |
[10] | Yang L, Zhang X, MacKay M, et al. Identification of radiorespon-sive genes in esophageal cancer from longitudinal and single cell exome sequencing[J]. Int J Radiat Oncol Biol Phys, 2020, 108(4): 1103-1114. DOI: 10.1016/j.ijrobp.2020.06.015. doi:10.1016/j.ijrobp.2020.06.015 |
[11] | Yang L, Zhang X, Hou Q, et al. Single-cell RNA-seq of esophageal squamous cell carcinoma cell line with fractionated irradiation reveals radioresistant gene expression patterns[J]. BMC Genomics, 2019, 20(1): 611. DOI: 10.1186/s12864-019-5970-0. doi:10.1186/s12864-019-5970-0pmid:31345182 |
[12] | Wu H, Yu J, Kong D, et al. Population and single-cell transcrip-tome analyses reveal diverse transcriptional changes associated with radioresistance in esophageal squamous cell carcinoma[J]. Int J Oncol, 2019, 55(6): 1237-1248. DOI: 10.3892/ijo.2019.4897. doi:10.3892/ijo.2019.4897 |
[13] | Hou Q, Jiang Z, Li Z, et al. Identification and functional validation of radioresistance-related genes AHNAK2 and EVPL in esophageal squamous cell carcinoma by exome and transcriptome sequencing analyses[J]. Onco Targets Ther, 2021, 14: 1131-1145. DOI: 10.2147/OTT.S291007. doi:10.2147/OTT.S291007 |
[14] | Chen Z, Huang Y, Hu Z, et al. Dissecting the single-cell tran-scriptome network in patients with esophageal squamous cell carcinoma receiving operative paclitaxel plus platinum chemothe-rapy[J]. Oncogenesis, 2021, 10(10): 71. DOI: 10.1038/s41389-021-00359-2. doi:10.1038/s41389-021-00359-2 |
[15] | Wu H, Chen S, Yu J, et al. Single-cell transcriptome analyses reveal molecular signals to intrinsic and acquired paclitaxel resistance in esophageal squamous cancer cells[J]. Cancer Lett, 2018, 420: 156-167. DOI: 10.1016/j.canlet.2018.01.059. doi:S0304-3835(18)30092-2pmid:29410067 |
[16] | Kumari N, Choi SH. Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies[J]. J Exp Clin Cancer Res, 2022, 41(1): 68. DOI: 10.1186/s13046-022-02272-x. doi:10.1186/s13046-022-02272-x |
[17] | Zheng Y, Chen Z, Han Y, et al. Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment[J]. Nat Commun, 2020, 11(1): 6268. DOI: 10.1038/s41467-020-20019-0. doi:10.1038/s41467-020-20019-0pmid:33293583 |
[18] | Zhang X, Peng L, Luo Y, et al. Dissecting esophageal squamous-cell carcinoma ecosystem by single-cell transcriptomic analysis[J]. Nat Commun, 2021, 12(1): 5291. DOI: 10.1038/s41467-021-25539-x. doi:10.1038/s41467-021-25539-xpmid:34489433 |
[19] | 秦斌. 基于单细胞转录组分析揭示食管鳞状细胞癌发展中的细胞状态[D]. 郑州大学, 2021. DOI: 10.27466/d.cnki.gzzdu.2021.003004. doi:10.27466/d.cnki.gzzdu.2021.003004 |
[20] | Chen Z, Zhao M, Liang J, et al. Dissecting the single-cell tran-scriptome network underlying esophagus non-malignant tissues and esophageal squamous cell carcinoma[J]. EBioMedicine, 2021, 69: 103459. DOI: 10.1016/j.ebiom.2021.103459. doi:10.1016/j.ebiom.2021.103459 |
[21] | Han L, Chen S, Chen Z, et al. Interleukin 32 promotes Foxp3+Treg cell development and CD8+T cell function in human esophageal squamous cell carcinoma microenvironment[J]. Front Cell Dev Biol, 2021, 9: 704853. DOI: 10.3389/fcell.2021.704853. doi:10.3389/fcell.2021.704853 |
[22] | Dinh HQ, Pan F, Wang G, et al. Integrated single-cell transcrip-tome analysis reveals heterogeneity of esophageal squamous cell carcinoma microenvironment[J]. Nat Commun, 2021, 12(1): 7335. DOI: 10.1038/s41467-021-27599-5. doi:10.1038/s41467-021-27599-5pmid:34921160 |
[23] | Yao J, Duan L, Huang X, et al. Development and validation of a prognostic gene signature correlated with M2 macrophage infiltration in esophageal squamous cell carcinoma[J]. Front Oncol, 2021, 11: 769727. DOI: 10.3389/fonc.2021.769727. doi:10.3389/fonc.2021.769727 |
[24] | Larsson AJM, Johnsson P, Hagemann-Jensen M, et al. Genomic encoding of transcriptional burst kinetics[J]. Nature, 2019, 565(7738): 251-254. DOI: 10.1038/s41586-018-0836-1. doi:10.1038/s41586-018-0836-1 |
[25] | Su Z, Wang Z, Ni X, et al. Inferring the evolution and progression of small-cell lung cancer by single-cell sequencing of circulating tumor cells[J]. Clin Cancer Res, 2019, 25(16): 5049-5060. DOI: 10.1158/1078-0432.CCR-18-3571. doi:10.1158/1078-0432.CCR-18-3571pmid:31113842 |
[26] | Massoni-Badosa R, Iacono G, Moutinho C, et al. Sampling time-dependent artifacts in single-cell genomics studies[J]. Genome Biol, 2020, 21(1): 112. DOI: 10.1186/s13059-020-02032-0. doi:10.1186/s13059-020-02032-0pmid:32393363 |
[1] | 杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊.局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337. |
[2] | 刘静, 刘芹, 黄梅.基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273. |
[3] | 万芳, 杨钢, 李睿, 万启晶.食管癌患者血清miR-497、miR-383水平及临床意义[J]. 国际肿瘤学杂志, 2024, 51(4): 204-209. |
[4] | 中国医师协会放射肿瘤治疗医师分会, 中华医学会放射肿瘤治疗学分会, 中国抗癌协会肿瘤放射治疗专业委员会.中国食管癌放射治疗指南(2023年版)[J]. 国际肿瘤学杂志, 2024, 51(1): 1-20. |
[5] | 高新雨, 李振江, 孙洪福, 韩丹, 赵倩, 刘成新, 黄伟.基于MR加速器的MR引导放疗在食管癌患者中的临床应用[J]. 国际肿瘤学杂志, 2024, 51(1): 37-42. |
[6] | 山东省医学会肺癌食管癌多学科联合委员会.山东省医学会食管癌多学科规范化诊疗指南(2023年版)[J]. 国际肿瘤学杂志, 2023, 50(7): 385-397. |
[7] | 崔曼莉, 路宁, 朱琳, 李茜, 张明鑫.基于高通量测序数据分析食管鳞状细胞癌circRNA的研究[J]. 国际肿瘤学杂志, 2023, 50(6): 328-335. |
[8] | 冀世玉, 张明鑫, 谢华红, 白渊, 王彤.不同支架治疗晚期食管癌患者的疗效观察[J]. 国际肿瘤学杂志, 2023, 50(2): 76-81. |
[9] | 巩合义, 伊艳, 张健, 李宝生.局部晚期可手术食管癌经新辅助放化疗达临床完全缓解后的处理策略[J]. 国际肿瘤学杂志, 2023, 50(12): 745-750. |
[10] | 吴浦嫄, 祁亮, 王涛, 史敏科, 孙雨薇, 王立峰, 刘宝瑞, 闫婧, 任伟.基于高频复发区改良临床靶区的术后放疗在食管鳞状细胞癌中的疗效研究[J]. 国际肿瘤学杂志, 2022, 49(8): 464-472. |
[11] | 戴李宸, 胡莉钧, 于静萍.尼妥珠单抗治疗食管鳞状细胞癌的应用进展[J]. 国际肿瘤学杂志, 2022, 49(8): 484-489. |
[12] | 夏玲玲, 陈永顺, 李彬, 宁婷婷, 张蔡羽天.pN+食管鳞状细胞癌患者R0切除术后放化疗与化疗的安全性及有效性比较[J]. 国际肿瘤学杂志, 2022, 49(6): 334-339. |
[13] | 王永洪, 何弢, 李星, 罗启余, 王乔羽.信迪利单抗致晚期鳞状细胞肺癌患者致死性中毒性表皮坏死松解症1例[J]. 国际肿瘤学杂志, 2022, 49(6): 380-382. |
[14] | 叶倩, 凌志, 刘申香, 路国涛, 殷旭东.肌肉减少症对老年食管癌患者根治性放疗临床疗效及预后的影响[J]. 国际肿瘤学杂志, 2022, 49(4): 199-205. |
[15] | 周剑烽, 王铁君.食管癌的靶向治疗及免疫治疗[J]. 国际肿瘤学杂志, 2022, 49(4): 237-242. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||